
No data
No data
No data
| CAS Number | 52-86-8 |
| Catalog Number | AG00DDQN(AGN-PC-0SDTZI) |
| Chemical Name | Haloperidol |
| IUPAC Name | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one |
| InChI | InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 |
| InChI Key | LNEPOXFFQSENCJ-UHFFFAOYSA-N |
| MDL Number | MFCD00051423 |
| Molecular Formula | C21H23ClFNO2 |
| Molecular Weight | 375.8642 |
| SMILES | ClC1=CC=C(C=C1)C1(CCN(CC1)CCCC(=O)C1=CC=C(C=C1)F)O |
| UNII | J6292F8L3D |
| Synonyms | Haldol,
Haloperidol,
haloperidol,
52-86-8,
Haldol,
Aloperidin,
Serenace,
Aloperidol,
Brotopon,
Eukystol,
Einalon S,
Aloperidolo,
Galoperidol,
Halojust,
Halopoidol,
Serenase,
Serenelfi,
Ulcolind,
Uliolind,
Vesalium,
Halopal,
Linton,
Mixidol,
Pernox,
Sernas,
Sernel,
Dozic,
Aldo,
Lealgin compositum,
Keselan,
Peluces,
Bioperidolo,
Haloperidolum,
Sigaperidol,
Haldol Solutab,
McN-JR-1625,
Aloperidon,
Fortunan,
Halosten,
Aloperidolo [DCIT],
Halidol,
Halopidol,
Pekuces,
Halol,
Aloperidolo [Italian],
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,
Haloperidolum [INN-Latin],
NSC 170973,
R 1625,
R-1625,
C21H23ClFNO2,
1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine,
UNII-J6292F8L3D,
CCRIS 1630,
Haloperidol (Haldol),
4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone,
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone,
HSDB 3093,
Haloperidol lactate,
CHEMBL54,
EINECS 200-155-6,
Haldol (TN),
NSC 615296,
4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone,
BRN 0331267,
1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-,
4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone,
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone,
MLS000028450,
CHEBI:5613,
LNEPOXFFQSENCJ-UHFFFAOYSA-N,
4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone,
4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone,
J6292F8L3D,
Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-,
1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-,
4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one,
NSC170973,
NSC615296,
CAS-52-86-8,
NCGC00015500-10,
SMR000058303,
4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone,
4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone,
gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone,
Haloperidol Intensol,
4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone,
Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-,
gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone,
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one,
DSSTox_CID_14150,
DSSTox_RID_79117,
DSSTox_GSID_34150,
61788-97-4,
W-105791,
Haloperido,
Peridol,
Dozix,
Apo-Haloperidol,
Pms Haloperidol,
Novo-Peridol,
Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-,
gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone,
Haldol La,
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one,
SR-01000003076,
Haloperidol [USAN:INN:BAN:JAN],
Duraperidol,
Resin epoxy,
4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone,
gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone,
4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone,
Picroside-III,
Haloperidol, 1,
Haloperidol, powder,
Haloperidol(Haldol),
Prestwick_250,
Phenolic epoxy resin,
Haloperidol [USAN:USP:INN:BAN:JAN],
MDMO-PPV,
Spectrum_000861,
Tocris-0931,
Opera_ID_446,
4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl),
Prestwick0_000115,
Prestwick1_000115,
Prestwick2_000115,
Prestwick3_000115,
Spectrum2_001268,
Spectrum3_000448,
Spectrum4_000570,
Spectrum5_000788,
Lopac-H-1512,
Biomol-NT_000035,
GTPL86,
Probes1_000255,
Probes2_000296,
H 1512,
AC1L1G7K,
SCHEMBL8264,
Lopac0_000583,
Oprea1_509923,
BSPBio_000130,
BSPBio_002096,
KBioGR_000980,
KBioGR_002390,
KBioSS_001341,
KBioSS_002395,
5-21-02-00377 (Beilstein Handbook Reference),
MLS001146904,
BIDD:GT0128,
DivK1c_000654,
SPECTRUM1500325,
SPBio_001236,
SPBio_002069,
McM-JR-1625,
AC1Q77Z0,
BPBio1_000144,
BPBio1_001231,
Haloperidol (JP17/USP/INN),
DTXSID4034150,
BDBM21398,
HMS502A16,
KBio1_000654,
KBio2_001341,
KBio2_002390,
KBio2_003909,
KBio2_004958,
KBio2_006477,
KBio2_007526,
KBio3_001316,
KBio3_002869,
LNEPOXFFQSENCJ-UHFFFAOYSA-,
AOB5645,
cMAP_000037,
NINDS_000654,
AC250,
HMS1568G12,
HMS1920D03,
HMS2089M15,
HMS2091J09,
HMS2095G12,
HMS2234P08,
HMS3261F08,
HMS3370H11,
HMS3657I13,
HMS3712G12,
Pharmakon1600-01500325,
ZINC537822,
Haloperidol 1.0 mg/ml in Methanol,
Tox21_110162,
Tox21_300475,
Tox21_500583,
A0H334,
BG0211,
CCG-36042,
CCG-39111,
IN1474,
MFCD00051423,
NSC757054,
STL417208,
AKOS000280660,
Tox21_110162_1,
API0002885,
CS-1971,
DB00502,
LP00583,
MCULE-3693790133,
NSC-170973,
NSC-615296,
NSC-757054,
IDI1_000654,
MRF-0000027,
QTL1_000042,
WLN: T6NTJ A3VR DF& DQ DR DG,
NCGC00015500-01,
NCGC00015500-02,
NCGC00015500-03,
NCGC00015500-04,
NCGC00015500-05,
NCGC00015500-06,
NCGC00015500-07,
NCGC00015500-08,
NCGC00015500-09,
NCGC00015500-11,
NCGC00015500-12,
NCGC00015500-13,
NCGC00015500-14,
NCGC00015500-15,
NCGC00015500-16,
NCGC00015500-17,
NCGC00015500-19,
NCGC00016234-01,
NCGC00023875-02,
NCGC00023875-04,
NCGC00023875-05,
NCGC00023875-06,
NCGC00023875-07,
NCGC00023875-08,
NCGC00023875-09,
NCGC00254503-01,
NCGC00261268-01,
177716-59-5,
AC-19691,
AN-41634,
CC-16450,
HY-14538,
LS-48311,
SC-81035,
ACM1189986591,
SBI-0050565.P004,
AB2000375,
SC 170973,
TR-018722,
AB00052008,
EU-0100583,
FT-0669100,
FT-0697842,
N1910,
S1920,
ST50319916,
SW196557-4,
W0039,
4763-EP2269989A1,
4763-EP2269990A1,
4763-EP2272537A2,
4763-EP2272972A1,
4763-EP2272973A1,
4763-EP2275420A1,
4763-EP2277872A1,
4763-EP2277876A1,
4763-EP2292614A1,
4763-EP2295061A1,
4763-EP2295412A1,
4763-EP2295413A1,
4763-EP2295439A1,
4763-EP2298731A1,
4763-EP2298776A1,
4763-EP2305260A1,
4763-EP2308867A2,
4763-EP2308870A2,
4763-EP2311801A1,
4763-EP2311803A1,
4763-EP2311824A1,
4763-EP2311837A1,
4763-EP2316834A1,
C01814,
D00136,
VU0239704-10,
AB00052008-21,
AB00052008-22,
AB00052008_23,
AB00052008_24,
C-35402,
L000288,
SR-01000003076-2,
SR-01000003076-8,
BRD-K67783091-001-04-8,
BRD-K67783091-001-05-5,
BRD-K67783091-003-03-6,
I14-13404,
I14-14165,
SR-01000003076-11,
Haloperidol, European Pharmacopoeia (EP) Reference Standard,
Poly[2-methoxy-5-(3,7-dimethyoctyoxyl)-1,4-phenylenevinylene],
.gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone,
Haloperidol, United States Pharmacopeia (USP) Reference Standard,
.gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone,
4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-one,
Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material,
4-[4-(4-Chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)- 1-butanone,
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone,
Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard,
Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard,
Haloperidol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2,
haloperin,
Neurodol,
Picroside III,
haloperidol-,
Epoxy resins,
Haldol decanoate,
Haloperidol D4,
Aloperidin (TN),
Bioperidolo (TN),
Duraperidol (TN),
Sigaperidol (TN),
Brotopon (TN),
Eukystol (TN),
Halosten (TN),
Serenace (TN),
Serenase (TN),
Keselan (TN),
Peluces (TN),
Linton (TN),
Einalon S (TN),
Dozic (TN),
Haloperidol (JP15/USP),
D0D1AL,
HALOPERIDOL DECANOATE,
McN-JR 1625,
CHEMBL545608,
Haloperidol (JP15/USP/INN),
CID3559,
C21-H23-Cl-F-N-O2,
Haloperidol [USAN:BAN:INN:JAN],
AC-250,
CS-T-25844,
B2099,
H0912,
A10446,
D006220,
64461-95-6,
1-(3-p-Fluorobenzoylpropil)-4-p-clorofenil-4-hidroxipiperidine 4,
Aloperidin;Bioperidolo;Brotopon;Dozic;Duraperidol;Einalon S;Haldol,
gamma-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone,
4-(4-Hydroxy-4''''-chloro-4-phenylpiperidino)-4''''-fluorobutyrophenone,
4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4''''-fluorobutyrophenone,
Butirofenona, 4-[4-(p-clorofenil)-4-] hidroxipiperidino-4'-fluoro-,
1-butanona, 4-[4-(4-clorofenil)-4-hidroxi-1-piperidinil]-1-(4-fluorofenil)-,
1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)-,
Butyrophenone 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-(6CI8CI),
1189986-59-1,
GMJ,
|
| Complexity | 451 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 375.14g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 375.868g/mol |
| Monoisotopic Mass | 375.14g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 40.5A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.2 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H225-H301+H311+H331-H370-H350-H360 |
| Packing Group | Ⅲ |
| Precautionary statements | P210-P280-P301+P310 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

